It was recently demonstrated how the P2Y6 receptor antagonist MRS2578 increased infarct volumes and worsened outcomes after tMCAO (Wen et al., 2020) in mice, lending evidence to microglial phagocytosis being a beneficial process in the aftermath of cerebral ischemia. Here, P2RY6 is linked to brain ischemia.